ADMA Biologics ADMA Deferred Tax Liabilities Right Of Use Asset
Deferred Tax Liabilities Right Of Use Asset at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept adma:DeferredTaxLiabilitiesRightOfUseAsset.
The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's deferred tax liabilities right of use asset.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's deferred tax liabilities right of use asset?
- ADMA Biologics (ADMA) reported deferred tax liabilities right of use asset of $2.05M in Q4 2025.
- What does deferred tax liabilities right of use asset mean?
- This represents the deferred tax liability arising from temporary differences between the carrying amount of right-of-use assets and their tax base. It reflects the future tax impact of accounting for operating leases under current financial reporting standards.